Status:
UNKNOWN
Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Non-Small Cell Lung Carcinoma
Venous Thromboembolism
Eligibility:
All Genders
Brief Summary
The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possibl...
Eligibility Criteria
Inclusion
- Histologically or cytologically confirmed diagnosis of NSCLC.
- normal serum bilirubin
- informed concent to participate in the study
Exclusion
- anticoagulant therapy
- infectious disease
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00192829
Start Date
June 1 2005
Last Update
April 11 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hematology Laboratory
Haifa, Israel
2
Oncology Institution, Rambam Health Campus
Haifa, Israel